Sylwia Szafraniec-Buryło

Publications

Citations

H-Index

2004

Active since

Affiliations

Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy(Current)

Sylwia Szafraniec-Buryło is an author at Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy specializing in cancer therapeutics, radiation oncology, and cancer research.

ORCID

Top concepts

HealthMedicineCancer TherapyCancer ResearchRadiation OncologySurgeryOncologyPathologyHematologyPharmacology

Publications per year

2004–2019

Publications

Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland

Melania Brzozowska, Waldemar Wierzba, Sylwia Szafraniec-Buryło et al. · Medical Science Monitor · 2019 · 19 citations · Full text

Overall Survival, Gastrointestinal Oncology, Medicine +14

New nucleoside analogs in the treatment of hematological disorders.

Sylwia Szafraniec-Buryło, Krzysztof Stachnik, Janusz Skierski · PubMed · 2004 · 18 citations

New Analogs, Medicinal Chemistry, New Nucleoside Analogs +13

Rows per page

1–2 of 2